The diagnostic criteria of pityriasis rosea and Gianotti-Crosti syndrome – a protocol to establish diagnostic criteria of skin diseases
- 1 September 2015
- journal article
- research article
- Published by SAGE Publications in Journal of the Royal College of Physicians of Edinburgh
- Vol. 45 (3), 218-225
- https://doi.org/10.4997/jrcpe.2015.310
Abstract
We established and validated diagnostic criteria for pityriasis rosea and Gianotti-Crosti syndrome. In this paper, we compare and contrast both diagnostic criteria to formulate a protocol in establishing diagnostic criteria for other dermatological diseases. The diagnostic criteria are similar in employing clear dividing lines and conjunctions (‘and/or') to assure high reliability. Both sets of criteria should be applicable for all ethnic groups. Spontaneous remission is not included, so diagnosis is not delayed while waiting for disease remission. Laboratory investigations are not enlisted, so that the criteria can be used in medical care systems in different parts of the world. The diagnostic criteria are different in that pathognomonic clinical manifestations exist for pityriasis rosea, such as the herald patch and the orientation of lesions along the lines of skin cleavages. These features, however, score low for sensitivity. These specific manifestations are not seen in Gianotti-Crosti syndrome. Such differences led to different categorisation of clinical features. Atypical variants are more common for pityriasis rosea. The diagnostic criteria for pityriasis rosea therefore do not include a list of differential diagnoses, while diagnostic criteria for Gianotti-Crosti syndrome do. Using this comparison, we constructed a protocol to establish diagnostic criteria for other skin diseases. We advocate the need to justify the establishment of diagnostic criteria, that multiple diagnostic criteria for the same disease should be avoided, that diagnostic criteria should be compatible with the disease classification if applicable, and that the scope should be well-delineated with regard to clinical variants. We outline the need for validation studies to assess the criteria-related validity, test-retest intra-clinician reliability, and inter-clinician reliability. We emphasise that the establishment of diagnostic criteria should not be a generic process. We also highlight limitations of diagnostic criteria, and emphasise that no diagnostic criteria can replace the bedside experience of clinicians.Keywords
This publication has 17 references indexed in Scilit:
- Applicability of proposed diagnostic criteria of pityriasis rosea: Results of a prospective case-control study in IndiaIndian Journal of Dermatology, 2013
- Follicular pityriasis rosea. A case report and a new classification of clinical variants of the disease.Journal of Dermatological Case Reports, 2012
- Gianotti-Crosti Syndrome, Pityriasis Rosea, Asymmetrical Periflexural Exanthem, Unilateral Mediothoracic Exanthem, Eruptive Pseudoangiomatosis and Papular-Purpuric Gloves and Socks Syndrome: A Brief Review and Arguments for Diagnostic CriteriaInfectious Disease Reports, 2012
- The Natural History of Pityriasis Rosea in Black American Children: How Correct Is the "Classic" Description?Archives of Pediatrics & Adolescent Medicine, 2007
- The detection of human herpesvirus‐8 DNA in plasma and peripheral blood mononuclear cells in adult patients with pityriasis rosea by polymerase chain reactionJournal of the European Academy of Dermatology and Venereology, 2006
- A New Concept: Paraviral EruptionsDermatology, 2005
- Atypical presentations of pityriasis rosea: case presentationsJournal of the European Academy of Dermatology and Venereology, 2004
- The Diagnostic Criteria of Gianotti-Crosti Syndrome: Are They Applicable to Children in India?Pediatric Dermatology, 2004
- Gianotti-Crosti Syndrome in India Is Not Associated with Hepatitis B InfectionDermatology, 2004
- Gianotti-Crosti syndrome: a study of 26 casesBritish Journal of Dermatology, 1986